Connect with us

Business

AOC ‘Concerned’ Biden’s Conservative Pot Views Could Ruin Bipartisan Push To Study Psychedelics

Published

on

Biden’s record is shadier than his Aviators when it comes to cannabis policy.

AOC is doing what we love her best for: calling out the old-guard Democrats. Alexandria Ocasio-Cortez, the Democratic Representative from New York, says she’s worried that President Joe Biden may derail bipartisan efforts to address psychedelics due to his past conservative comments about cannabis usage, Business Insider reports

“I believe the president has displayed a regressiveness for cannabis policy,” she said, making it clear that she has concerns about Biden’s approach to cannabis and psychedelics. “And if there’s a regressiveness toward cannabis policy, it’s likely to be worse on anything else,” AOC added. 

Cannabis and “classical” psychedelics, such as LSD and psilocybin, have been gaining the American people’s public acceptance. In June, a study found that Americans say cannabis is much less dangerous than opioids, alcohol, and cigarettes. 

Recently, during an interview with The Michael Smerconish Program on SiriusXM Wednesday, the president’s brother, Frank Biden, shared that the president might be down with psychedelics. “He is very open-minded,” Frank Biden responded when asked by Smerconish about discussions with his presidential brother about the medical benefits of psychedelics.” 

In 2022, Biden announced that he will pardon people with federal convictions for simple possession of cannabis. The president also announced that he will direct the U.S. Attorney General Merrick B. Garland and Secretary of the Department of Health and Human Services Xavier Becerra to begin the process of reviewing the classification of cannabis at the federal level.

And, in late June, the FDA issued the first-ever guidance for psychedelic clinical studies. They filed the 14-page document following Congress-introduced bipartisan legislation led by Texas Republican Representative Dan Crenshaw, directing the issuance of clinical trial guidelines. 

However, this hasn’t convinced AOC that President Biden, the leader of the federal government, is committed to honoring the public’s changing viewpoints based on how he has talked about marijuana in the past. “I am concerned about the president,” Ocasio-Cortez of New York told The Washington Post

And she’s not wrong to question his flip-flopping policy. Back during the 2020 election, Leafly pointed out that Biden was the only Democratic presidential candidate that was against federal legalization. Only a few years ago, in 2019, Biden said cannabis could be a “gateway drug,” one of the foulest expressions in the English language to the cannabis connoisseur. 

“The truth of the matter is, there’s not nearly been enough evidence that has been acquired as to whether or not it is a gateway drug,” the then-presidential hopeful said during a town hall event. “It’s a debate, and I want a lot more before I legalize it nationally. I want to make sure we know a lot more about the science behind it.”

However, once Biden realized it was only him and Donald Trump against federal legalization, he quickly changed his tune. Since entering office, he has kept a safe distance from drug policy but, as mentioned, has stated that federal legalization is in the future. However, Ocasio-Cortez says other lawmakers’ reactions regarding pro-psychedelic legislation tells another story. 

According to AOC, when she first introduced the legislation, an unnamed senior member of her party laughed at her. “Oh, is this your little ‘shrooms bill?’” Ocasio-Cortez said the lawmaker told her. She and Crenshaw added amendments that would increase access to psychedelic treatments for veterans and active-duty service members with mental health conditions, which were tacked on to the annual National Defense Authorization Act.

Florida Republican Representative Matt Gaetz, who recently proposed ending drug testing for the military, says the congressional “gerontocracy” is why lawmakers of both parties (the psychedelic movement is a surprisingly bipartisan effort), in line with AOC’s observation that politicians like Biden, are stuck in regressive viewpoints. 

However, even if Biden came off as anti-cannabis just four years ago, and even if that’s how he feels, given recent activity, it’s clear that he’s realized that if the president wants to stay in the game, he must embrace cannabis and psychedelics as valid medicines. Most folks in the movement would take federal deregulation, even if it comes from lawmakers’ efforts to look cool rather than what lives in their hearts. 

Source: https://hightimes.com/news/aoc-concerned-bidens-conservative-pot-views-could-ruin-bipartisan-push-to-study-psychedelics/

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News